Treatment-associated musculoskeletal and vasomotor symptoms and relapse-free survival in the NCIC CTG MA.27 adjuvant breast cancer aromatase inhibitor trial

Vered Stearns, Judith Anne W. Chapman, Aurélie Le Maitre, Jessica Kundapur, Lois E. Shepherd, Kathleen I. Pritchard, Cynthia X. Ma, Matthew J. Ellis, James N. Ingle, G. Thomas Budd, George W. Sledge, Pedro E.R. Liedke, Paul E. Goss, Paul E. Goss, Manuela Rabaglio, Pedro E.R. Liedke

Research output: Contribution to journalArticlepeer-review

27 Scopus citations

Fingerprint

Dive into the research topics of 'Treatment-associated musculoskeletal and vasomotor symptoms and relapse-free survival in the NCIC CTG MA.27 adjuvant breast cancer aromatase inhibitor trial'. Together they form a unique fingerprint.

Medicine & Life Sciences